GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (XSGO:LLYCL) » Definitions » E10

Eli Lilly and Co (XSGO:LLYCL) E10 : CLP5,468.63 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Eli Lilly and Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Eli Lilly and Co's adjusted earnings per share data for the three months ended in Sep. 2024 was CLP934.056. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is CLP5,468.63 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Eli Lilly and Co's average E10 Growth Rate was 14.80% per year. During the past 3 years, the average E10 Growth Rate was 8.40% per year. During the past 5 years, the average E10 Growth Rate was 8.90% per year. During the past 10 years, the average E10 Growth Rate was 6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Eli Lilly and Co was 13.50% per year. The lowest was -2.70% per year. And the median was 5.20% per year.

As of today (2024-12-11), Eli Lilly and Co's current stock price is CLP782700.00. Eli Lilly and Co's E10 for the quarter that ended in Sep. 2024 was CLP5,468.63. Eli Lilly and Co's Shiller PE Ratio of today is 143.13.

During the past 13 years, the highest Shiller PE Ratio of Eli Lilly and Co was 172.05. The lowest was 23.03. And the median was 37.95.


Eli Lilly and Co E10 Historical Data

The historical data trend for Eli Lilly and Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co E10 Chart

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Eli Lilly and Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 5,308.76 5,468.63

Competitive Comparison of Eli Lilly and Co's E10

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Shiller PE Ratio falls into.



Eli Lilly and Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=934.056/133.0289*133.0289
=934.056

Current CPI (Sep. 2024) = 133.0289.

Eli Lilly and Co Quarterly Data

per share eps CPI Adj_EPS
201412 234.338 99.070 314.665
201503 313.435 99.621 418.545
201506 355.365 100.684 469.527
201509 528.510 100.392 700.329
201512 306.163 99.792 408.133
201603 276.791 100.470 366.488
201606 469.658 101.688 614.409
201609 481.128 101.861 628.346
201612 467.823 101.863 610.959
201703 -66.266 102.862 -85.700
201706 630.050 103.349 810.988
201709 337.530 104.136 431.181
201712 -972.048 104.011 -1,243.237
201803 702.102 105.290 887.077
201806 -161.987 106.317 -202.686
201809 740.880 106.507 925.373
201812 740.485 105.998 929.319
201903 2,935.498 107.251 3,641.065
201906 978.998 108.070 1,205.104
201909 994.182 108.329 1,220.859
201912 1,163.134 108.420 1,427.138
202003 1,354.080 108.902 1,654.080
202006 1,265.358 108.767 1,547.608
202009 1,043.332 109.815 1,263.884
202012 1,613.086 109.897 1,952.623
202103 1,090.844 111.754 1,298.506
202106 1,124.978 114.631 1,305.529
202109 980.380 115.734 1,126.882
202112 1,567.904 117.630 1,773.165
202203 1,653.036 121.301 1,812.859
202206 965.968 125.017 1,027.875
202209 1,555.260 125.227 1,652.162
202212 1,768.085 125.222 1,878.318
202303 1,176.087 127.348 1,228.553
202306 1,565.226 128.729 1,617.513
202309 -54.410 129.860 -55.738
202312 2,112.539 129.419 2,171.458
202403 2,164.916 131.776 2,185.496
202406 2,863.276 132.554 2,873.539
202409 934.056 133.029 934.056

Add all the adjusted EPS together and divide 10 will get our e10.


Eli Lilly and Co  (XSGO:LLYCL) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eli Lilly and Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=782700.00/5468.63
=143.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Eli Lilly and Co was 172.05. The lowest was 23.03. And the median was 37.95.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Eli Lilly and Co E10 Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co Business Description

Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Eli Lilly and Co Headlines

No Headlines